1003941-33-0Relevant academic research and scientific papers
New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)
Zhao, Nan,Ma, Yao,Zhang, Shengmei,Fang, Xin,Liang, Zhenglun,Liu, Gang
supporting information; experimental part, p. 4292 - 4295 (2011/08/10)
A series of new muramyl dipeptide (MDP) mimics were designed and synthesized via a solid-phase synthetic route. Their adjuvant activities were evaluated ex vivo for investigation of the synergism of the S28-39 peptide, which is an MHC class I b
